Fact CheckerSign in

NCT07131527Completed

Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy

Comparative Study Between the Efficacy of Pre- Operative Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia in Adult Undergoing Laparoscopic Cholecystectomy

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

this study amis to compare between perioperative oral Gabapentin versus Diclofenac sodium on postoperative analgesia patients undergoing laparoscopic cholecystectomy

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
13 Aug 2025
Start date
14 Jul 2025
Primary completion date
20 Jan 2026
Lead sponsor
Sohag University
NCT number
NCT07131527

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 14 Jul 2025 to the primary completion date, 20 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with hypertension. Pregnant women. Obese patients with BMI \>35 kg/m2. Alcoholics. Patients With DM Patient refusal

Who the study is looking for

  • Age from 20 to 60 years old. Both sexes. American Society of Anesthesiologists (ASA) physical status I- II. Patients undergoing laparoscopic cholecystectomy.

Age in the registry: 20 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sohag University Hospital
Coordinator of this site? Confirm its status
SohagEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.